. Adriamycin, or CFM-4.16 inhibit cell growth, elevate CARP-1 expression, and induce activation of JNKs and H2AX, and apoptosis. (A) MDA-MB-468 cells were either treated with DMSO (Control) or Adriamycin for indicated dose and time. Cell viability was determined by MTT assay. The columns in the bar chart represent means of three independent experiments; bars, SE. The kidney cancer UOK262 (B) or HeLa (C) cells were either untreated (noted as 0), treated with Adriamycin or CFM-4.16 for noted dose and time. Cell lysates were analyzed by WB as in Methods for levels of CARP-1, phospho-and total JNK1/2, phospho and total p53, and γH2AX. The western blot membranes were subsequently probed with anti-actin antibodies to assess equal loading. The presence of respective protein is indicated by an arrowhead on the left side of each blot. Approximate location of various molecular weight markers is indicated on the right side of each blot. kDa, kilodalton.
were subjected to quantitation for levels of H2AX. The quantitation of the images of stained cells was carried out by using ImageJ software (imagej.nih.gov/ij/plugins/track/jacop2). The columns in the bar chart represent average fluorescence from H2AX-stained cells in five random cells of each of the respective row.
